Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome ― The ODYSSEY J-IVUS Trial ―

Alirocumab Atheroma Intravascular Ultrasound
DOI: 10.1253/circj.cj-19-0412 Publication Date: 2019-08-19T22:04:01Z
ABSTRACT
Background:In patients with acute coronary syndrome (ACS), alirocumab reduced the risk of recurring ischemic events. ODYSSEY J-IVUS assessed effect on atheroma volume in Japanese recently hospitalized ACS and hypercholesterolemia, using intravascular ultrasound imaging analysis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (58)